• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Experts flag eye inflammation reports tied to Apellis' geographic atrophy med Syfovre

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 18, 2023 at 11:32: AM
via Apellis Pharmaceuticals' Syfovre, after achieving the first FDA approval for advanced eye disease geographic atrophy, has been associated with rare but severe side effects, according to the American Society of Retinal Specialists (ASRS).

article source
 




Top Bottom
Back
Quote